GHRP-6
Research-Grade
GHRP-6 is a synthetic hexapeptide, the first GHRP developed (1980s) and the one that led to the identification of the GHSR-1a receptor (before ghrelin itself was discovered). Structurally distinct from later GHRPs, it potently stimulates GH release but also drives substantial ghrelin-like appetite stimulation — which can be a feature (for bulking, or wasting-syndrome indications) or a bug (for most contemporary users). Compared to Ipamorelin: GHRP-6 causes substantially more hunger, elevates cortisol and prolactin more, and has a less clean safety profile in repeated-dose human studies. Contemporary off-label practice has largely replaced it with Ipamorelin. Its continued use is mostly in lean individuals seeking appetite stimulation for weight gain or in wasting-syndrome research.
Specifications
| Origin / Manufacturer | Synthetic |
| Form Factor | Lyophilized powder vial |
Frequently Asked Questions
Sources & References
Every clinical claim on this page traces to a primary peer-reviewed source.
- 1Bowers CY, Momany FA, Reynolds GA, Hong A. On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology. 1984;114:1537-1545. PMID:6423369
Reviewed by
Clinical Research Review Board
Pharmacology & Endocrinology Review
All clinical claims cross-checked against primary sources. Read our editorial policy →